Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Reduces Position in Kenvue Inc. $KVUE

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group lessened its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 32.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,051 shares of the company’s stock after selling 16,952 shares during the period. Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group’s holdings in Kenvue were worth $755,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Pittenger & Anderson Inc. purchased a new stake in shares of Kenvue in the first quarter valued at approximately $30,000. TruNorth Capital Management LLC purchased a new stake in Kenvue in the 1st quarter valued at $36,000. Truvestments Capital LLC purchased a new stake in Kenvue in the 1st quarter valued at $37,000. Trust Co. of Vermont grew its holdings in Kenvue by 266.8% in the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after buying an additional 1,150 shares in the last quarter. Finally, Clal Insurance Enterprises Holdings Ltd grew its holdings in Kenvue by 378.5% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock valued at $39,000 after buying an additional 1,287 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on KVUE shares. JPMorgan Chase & Co. dropped their price objective on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Rothschild & Co Redburn raised shares of Kenvue from a “neutral” rating to a “buy” rating and dropped their price target for the company from $22.50 to $22.00 in a research note on Friday, September 26th. Redburn Partners set a $22.00 price target on shares of Kenvue in a research note on Friday, September 26th. Evercore ISI dropped their price target on shares of Kenvue from $23.00 to $18.00 and set an “in-line” rating for the company in a research note on Tuesday, September 23rd. Finally, The Goldman Sachs Group lowered their price objective on Kenvue from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Thursday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus target price of $20.75.

Kenvue Trading Down 0.6%

Shares of KVUE stock opened at $15.00 on Monday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The firm has a market cap of $28.78 billion, a PE ratio of 20.26, a price-to-earnings-growth ratio of 2.16 and a beta of 0.72. The company has a 50-day moving average of $17.91 and a two-hundred day moving average of $20.79. Kenvue Inc. has a 1-year low of $14.05 and a 1-year high of $25.17.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. The firm had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm’s quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter last year, the company posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. This is an increase from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.83 annualized dividend and a dividend yield of 5.5%. The ex-dividend date was Wednesday, August 13th. Kenvue’s dividend payout ratio (DPR) is 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.